Skip to main content
. 2022 Jul 4;13:943333. doi: 10.3389/fimmu.2022.943333

Figure 2.

Figure 2

Licensing factors that activate the HIF-1α pathway in MSCs lead to increased glycolysis and allow for the immunomodulatory actions carried out by MSCs. Created with BioRender.com.